Breaking News Instant updates and real-time market news.

MNKD

MannKind

$1.17

0.02 (1.74%)

08:07
06/03/19
06/03
08:07
06/03/19
08:07

MannKind says Afrezza inhalation powder approved in Brazil

MannKind Corporation announced that Afrezza Inhalation Powder, an ultra rapid-acting mealtime insulin to improve glycemic control in adult patients with diabetes mellitus, has been registered by the Brazilian Health Regulatory Agency. The commercialization of Afrezza in Brazil is expected to begin in the fourth quarter this year, subject to the pricing registration process by Camara de Regulacao do Mercado de Medicamentos. "The regulatory approval of Afrezza in Brazil is an important milestone for MannKind and our partner Biomm. It not only represents our first international approval of Afrezza, but more importantly, we now have the opportunity to bring a novel mealtime insulin therapy to patients in a country with one of the highest prevalence of diabetes in the world, according to the International Diabetes Federation," said Michael Castagna, CEO.

MNKD MannKind
$1.17

0.02 (1.74%)

03/04/19
03/04/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. MannKind (MNKD) initiated with an Outperform at SVB Leerink. 2. Invitae (NVTA) initiated with a Buy at Chardan. 3. Immunomedics (IMMU) initiated with a Buy at H.C. Wainwright. 4. Canopy Growth (CGC) initiated with a Neutral at Melius Research. 5. Alector (ALEC) initiated with an Overweight at Morgan Stanley and Barclays, an Outperform at SVB Leerink and Cowen, as well as a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/08/19
HCWC
05/08/19
NO CHANGE
Target $3
HCWC
Buy
MannKind price target lowered to $3 from $4 at H.C. Wainwright
H.C. Wainwright analyst Oren Livnat lowered his price target for MannKind to $3 from $4 saying that while Q2 is already shaping up better than Q1, the slower Afrezza ramp drives an estimate reduction. The analyst, however, still believes MannKind's pipeline "is all potential upside" to his model. He keeps a Buy rating on the shares.
05/14/19
BTIG
05/14/19
INITIATION
Target $3
BTIG
Buy
MannKind initiated with a Buy, $3 price target at BTIG
BTIG analyst Robert Hazlett initiated coverage of MannKind with a Buy rating and $3 price target. The stock closed Monday down 2c to $1.23. With the advancements of continuous glucose monitor technologies, tighter glycemic control will become more of a focus, and MannKind's Afrezza "can play a material role," Hazlett tells investors in a research note. The analyst estimates inhaled insulin Afrezza's peak U.S. sales at greater than $350M. Mannkind's recently revamped management is attempting to energize Afrezza through publications of differentiating data, which can improve acceptance among physicians and patients, helping "solid growth continue," according to Hazlett.
05/14/19
05/14/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. MannKind (MNKD) initiated with a Buy, $3 price target at BTIG. 2. Ross Stores (ROST) and TJX (TJX) initiated with an Outperform at Baird. 3. Elastic (ESTC) initiated with a Hold at Stifel. 4. CytomX Therapeutics (CTMX) initiated with an Overweight at Cantor Fitzgerald. 5. FIS (FIS) initiated with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

GIL

Gildan Activewear

$26.27

-9.105 (-25.74%)

06:36
10/21/19
10/21
06:36
10/21/19
06:36
Downgrade
Gildan Activewear rating change  »

Gildan Activewear…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

OPRT

Oportun Financial

$15.89

-0.22 (-1.37%)

06:36
10/21/19
10/21
06:36
10/21/19
06:36
Initiation
Oportun Financial initiated  »

Oportun Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONB

Old National Bancorp

$17.19

0.11 (0.64%)

06:35
10/21/19
10/21
06:35
10/21/19
06:35
Earnings
Old National Bancorp reports Q3 adjusted EPS 41c, consensus 34c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 13

    Nov

GIL

Gildan Activewear

$26.27

-9.105 (-25.74%)

06:33
10/21/19
10/21
06:33
10/21/19
06:33
Upgrade
Gildan Activewear rating change  »

Gildan Activewear…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

KNOP

KNOT Offshore Partners

$19.50

0.02 (0.10%)

06:32
10/21/19
10/21
06:32
10/21/19
06:32
Initiation
KNOT Offshore Partners initiated  »

KNOT Offshore Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

BXBLY

Brambles

$0.00

(0.00%)

06:29
10/21/19
10/21
06:29
10/21/19
06:29
Upgrade
Brambles rating change  »

Brambles upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVX

Chevron

$114.79

-0.55 (-0.48%)

06:28
10/21/19
10/21
06:28
10/21/19
06:28
Periodicals
U.S. considers extension of Chevron's Venezuela waiver, Bloomberg says »

The U.S. is considering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

AUB

Atlantic Union Bankshares

$37.68

0.37 (0.99%)

06:27
10/21/19
10/21
06:27
10/21/19
06:27
Upgrade
Atlantic Union Bankshares rating change  »

Atlantic Union Bankshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Nov

  • 13

    Nov

  • 10

    Dec

DTE

DTE Energy

$127.38

-2.11 (-1.63%)

06:26
10/21/19
10/21
06:26
10/21/19
06:26
Upgrade
DTE Energy rating change  »

DTE Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 10

    Nov

  • 10

    Nov

  • 10

    Nov

CME

CME Group

$213.11

0.08 (0.04%)

, NDAQ

Nasdaq

$98.69

0.32 (0.33%)

06:26
10/21/19
10/21
06:26
10/21/19
06:26
Recommendations
CME Group, Nasdaq analyst commentary  »

Citi reiterates Buy on…

CME

CME Group

$213.11

0.08 (0.04%)

NDAQ

Nasdaq

$98.69

0.32 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 30

    Oct

  • 19

    Nov

BA

Boeing

$344.09

-25.04 (-6.78%)

06:25
10/21/19
10/21
06:25
10/21/19
06:25
Periodicals
Boeing board meets in Texas amid intensifying scrutiny, Reuters reports »

Boeing's board met…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

RES

RPC, Inc.

$4.61

0.065 (1.43%)

06:21
10/21/19
10/21
06:21
10/21/19
06:21
Upgrade
RPC, Inc. rating change  »

RPC, Inc. upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

GOLD

Barrick Gold

$17.20

0.095 (0.56%)

06:20
10/21/19
10/21
06:20
10/21/19
06:20
Hot Stocks
Barrick Gold preparing to restart gold mining in Tanzania »

The government of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

PTON

Peloton

$23.44

-0.41 (-1.72%)

06:19
10/21/19
10/21
06:19
10/21/19
06:19
Initiation
Peloton initiated  »

Peloton initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DTE

DTE Energy

$127.38

-2.11 (-1.63%)

06:19
10/21/19
10/21
06:19
10/21/19
06:19
Upgrade
DTE Energy rating change  »

DTE Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 10

    Nov

  • 10

    Nov

  • 10

    Nov

PTON

Peloton

$23.44

-0.41 (-1.72%)

06:19
10/21/19
10/21
06:19
10/21/19
06:19
Initiation
Peloton initiated  »

Peloton initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$67.62

-0.53 (-0.78%)

06:18
10/21/19
10/21
06:18
10/21/19
06:18
Periodicals
Exxon Mobil climate-change accounting case heads to court, WSJ reports »

Exxon Mobil Corp. and New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

COMM

CommScope

$11.56

-0.06 (-0.52%)

06:16
10/21/19
10/21
06:16
10/21/19
06:16
Upgrade
CommScope rating change  »

Nomura upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 07

    Nov

  • 09

    Dec

PTON

Peloton

$23.44

-0.41 (-1.72%)

06:16
10/21/19
10/21
06:16
10/21/19
06:16
Initiation
Peloton initiated  »

Peloton initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTON

Peloton

$23.44

-0.41 (-1.72%)

06:16
10/21/19
10/21
06:16
10/21/19
06:16
Initiation
Peloton initiated  »

Peloton initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTON

Peloton

$23.44

-0.41 (-1.72%)

06:14
10/21/19
10/21
06:14
10/21/19
06:14
Initiation
Peloton initiated  »

Peloton initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTON

Peloton

$23.44

-0.41 (-1.72%)

06:14
10/21/19
10/21
06:14
10/21/19
06:14
Initiation
Peloton initiated  »

Peloton initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPE

HP Enterprise

$15.36

0.16 (1.05%)

06:13
10/21/19
10/21
06:13
10/21/19
06:13
Upgrade
HP Enterprise rating change  »

HP Enterprise…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 09

    Dec

CBS

CBS

$36.75

-1 (-2.65%)

, VIAB

Viacom

$22.05

-0.56 (-2.48%)

06:12
10/21/19
10/21
06:12
10/21/19
06:12
Recommendations
CBS, Viacom analyst commentary  »

Barclays cuts CBS target…

CBS

CBS

$36.75

-1 (-2.65%)

VIAB

Viacom

$22.05

-0.56 (-2.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 14

    Nov

SXT

Sensient

$60.17

-6.4 (-9.61%)

06:11
10/21/19
10/21
06:11
10/21/19
06:11
Downgrade
Sensient rating change  »

Sensient downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.